Clough Capital
Clough Capital Clough is a Boston-based investment advisory firm which manages approximately $3.9 billion in assets: $1.7 billion in hedge fund and institutional accounts; $92 million in open-end mutual funds; and $2.1 billion in three closed-end funds (as of February 28, 2011) - Clough Global Allocation (GLV), Clough Global Equity (GLQ), and the Clough Global Opportunities Fund (GLO). The firm uses a global and theme-based approach and invests in securities on a global basis. Clough was founded in 2000 by Chuck Clough and partners James Canty and Eric Brock. These three are the portfolio managers for the Clough Global Allocation Fund.
View Older Stories View More Recent Stories
-
Clough Global Equity Fund Announces Preliminary Results Of Rights Offering
-
Clough Capital Partners L.P. Announces Market Update Call
-
Clough Capital Partners L.P. Announces Market Update Call
-
Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 4 Clough Global Dividend For: May 19 Filed by: Clough Capital Partners, L.P.
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Clough Global Equity Fund Announces Rights Offering
-
Clough Global Dividend And Income Fund Announces Rights Offering
-
Clough Global Opportunities Fund Announces Rights Offering
-
Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies
-
Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies
-
Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for April, May, and June 2021 Of $0.0967 Per Share
-
Clough Global Equity Fund Declares Monthly Cash Distributions for April, May, and June 2021 of $0.1341 per Share
-
Clough Global Opportunities Fund Declares Monthly Cash Distributions For April, May, And June 2021 Of $0.1087 Per Share
-
Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
-
Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Clough Global Dividend And Income Fund Declares Monthly Cash Distributions For January, February, And March 2021 Of $0.0967 Per Share
-
Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, And March 2021 Of $0.1341 Per Share
-
Clough Global Opportunities Fund Declares Monthly Cash Distributions for January, February, and March 2021 of $0.1087 Per Share
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form SC 13G Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
-
Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
-
Clough Capital Partners Strengthens Healthcare Research Capabilities with the Addition of Dr. Noelle Tune
-
Clough Global Opportunities Fund Declares Monthly Cash Distributions for October, November, and December 2020 of $0.0897 Per Share
-
Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for October, November, and December 2020 of $0.1008 Per Share
-
Clough Global Equity Fund Declares Monthly Cash Distributions for October, November, and December 2020 of $0.1104 Per Share
-
Form 4 Clough Global Equity For: Aug 26 Filed by: Clough Capital Partners, L.P.
-
Form 4 Clough Global Opportunit For: Aug 26 Filed by: Clough Capital Partners, L.P.
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Clough Global Opportunities Fund Declares Monthly Cash Distributions For July, August, And September 2020 Of $0.0897 Per Share
-
Clough Global Dividend And Income Fund Declares Monthly Cash Distributions For July, August, And September 2020 Of $0.1008 Per Share
-
Clough Global Equity Fund Declares Monthly Cash Distributions For July, August, And September 2020 Of $0.1104 Per Share
-
Clough Global Dividend and Income Fund, Clough Global Equity Fund and Clough Global Opportunities Fund Announce Change of Location of the Joint Annual Meeting of Shareholders
-
Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Clough Global Opportunities Fund Declares A Monthly Cash Distribution For April, May, And June 2020 Of $0.0897 Per Share
-
Clough Global Dividend And Income Fund Declares A Monthly Cash Distribution For April, May, And June 2020 Of $0.1008 Per Share
-
Clough Global Equity Fund Declares A Monthly Cash Distribution For April, May, And June 2020 Of $0.1104 Per Share
-
Form SC 13G Correvio Pharma Corp. Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Clough Global Dividend and Income Fund Declares a Monthly Cash Distribution of $0.1008 Per Share
-
Clough Global Opportunities Fund Declares A Monthly Cash Distribution Of $0.0897 Per Share
-
Clough Global Equity Fund Declares A Monthly Cash Distribution Of $0.1104 Per Share
-
Clough Global Opportunities Fund Declares A Monthly Cash Distribution Of $0.0889 Per Share
-
Clough Global Equity Fund Declares A Monthly Cash Distribution Of $0.1091 Per Share
-
Clough Global Dividend And Income Fund Declares A Monthly Cash Distribution Of $0.1008 Per Share
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30

